Search hospitals > California > Duarte
City of Hope Comprehensive Cancer Center
Claim this profileDuarte, California 91010
Global Leader in Cancer
Global Leader in Lung Cancer
Conducts research for Breast Cancer
Conducts research for Lymphoma
Conducts research for Solid Tumors
2114 reported clinical trials
157 medical researchers
Summary
City of Hope Comprehensive Cancer Center is a medical facility located in Duarte, California. This center is recognized for care of Cancer, Lung Cancer, Breast Cancer, Lymphoma, Solid Tumors and other specialties. City of Hope Comprehensive Cancer Center is involved with conducting 2,114 clinical trials across 1,159 conditions. There are 157 research doctors associated with this hospital, such as Daneng Li, MD, Anna Pawlowska, MD, Mark Agulnik, and Vincent Chung, MD.Area of expertise
1Cancer
Global LeaderStage IV
Stage III
Stage II
2Lung Cancer
Global LeaderStage IV
Stage III
EGFR positive
Top PIs
Daneng Li, MDCity of Hope6 years of reported clinical research
Expert in Liver Cancer
Studies Hepatocellular Carcinoma
27 reported clinical trials
42 drugs studied
Anna Pawlowska, MDCity of Hope Comprehensive Cancer Center8 years of reported clinical research
Studies Cancer
Studies Non-Hodgkin's Lymphoma
26 reported clinical trials
63 drugs studied
Mark AgulnikCity of Hope3 years of reported clinical research
Expert in Soft Tissue Sarcoma
Studies Cancer
23 reported clinical trials
34 drugs studied
Vincent Chung, MDCity of Hope Medical Center3 years of reported clinical research
Expert in Pancreatic Cancer
Studies Lung Cancer
21 reported clinical trials
33 drugs studied
Clinical Trials running at City of Hope Comprehensive Cancer Center
Prostate Cancer
Skin Cancer
Breast Cancer
Lung Cancer
Breast cancer
Kidney Cancer
Ovarian Cancer
Cancer
Pancreatic Cancer
Multiple Myeloma
Docetaxel + Hormone Therapy
for Prostate Cancer
This study is being done to answer the following question: can the chance of prostate cancer growing or spreading be lowered by adding a drug to the usual combination of drugs? This study would like to find out if this approach is better or worse than the usual approach for prostate cancer. The usual approach for patients who are not in a study is hormone treatment with Androgen Deprivation Therapy (ADT) and Androgen-Receptor Pathway Inhibitor (ARPI).
Recruiting2 awards Phase 35 criteria
Ifinatamab Deruxtecan
for Prostate Cancer
Researchers are looking for new ways to treat metastatic castration-resistant prostate cancer (mCRPC). Researchers have designed a study medicine called ifinatamab deruxtecan (also called I-DXd or MK-2400) to treat mCRPC. The goal of this study is to learn if people who receive I-DXd live longer overall and live longer without the cancer growing or spreading than people who receive chemotherapy,
Recruiting2 awards Phase 32 criteria
Apalutamide + Targeted Radiation
for Prostate Cancer
This phase III trial tests two questions by two separate comparisons of therapies. The first question is whether enhanced therapy (apalutamide in combination with abiraterone + prednisone) added to standard of care (prostate radiation therapy and short term androgen deprivation) is more effective compared to standard of care alone in patients with prostate cancer who experience biochemical recurrence (a rise in the blood level of prostate specific antigen \[PSA\] after surgical removal of the prostate cancer). A second question tests treatment in patients with biochemical recurrence who show prostate cancer spreading outside the pelvis (metastasis) by positron emission tomography (PET) imaging. In these patients, the benefit of adding metastasis-directed radiation to enhanced therapy (apalutamide in combination with abiraterone + prednisone) is tested. Diagnostic procedures, such as PET, may help doctors look for cancer that has spread to the pelvis. Androgens are hormones that may cause the growth of prostate cancer cells. Apalutamide may help fight prostate cancer by blocking the use of androgens by the tumor cells. Metastasis-directed targeted radiation therapy uses high energy rays to kill tumor cells and shrink tumors that have spread. This trial may help doctors determine if using PET results to deliver more tailored treatment (i.e., adding apalutamide, with or without targeted radiation therapy, to standard of care treatment) works better than standard of care treatment alone in patients with biochemical recurrence of prostate cancer.
Recruiting2 awards Phase 3
Similar Hospitals nearby
Select from list below to view details
Frequently asked questions
What kind of research happens at City of Hope Comprehensive Cancer Center?
City of Hope Comprehensive Cancer Center is a medical facility located in Duarte, California. This center is recognized for care of Cancer, Lung Cancer, Breast Cancer, Lymphoma, Solid Tumors and other specialties. City of Hope Comprehensive Cancer Center is involved with conducting 2,114 clinical trials across 1,159 conditions. There are 157 research doctors associated with this hospital, such as Daneng Li, MD, Anna Pawlowska, MD, Mark Agulnik, and Vincent Chung, MD.
Where is City of Hope Comprehensive Cancer Center located?
**City of Hope Comprehensive Cancer Center**
- **Location:** 1500 E Duarte Rd, Duarte, CA
- **Accessibility:** Conveniently accessible from the 210 Freeway, near the intersection of Duarte Road and Royal Oaks Drive.
Who should I call to ask about financial aid or insurance network?
**City of Hope Comprehensive Cancer Center Financial and Insurance Assistance Services:**
- **Financial Counselors:** Offer financial counseling, benefits explanation, out-of-pocket cost estimates, insurance authorization, and medical necessity screening.
- **Patient Resource Coordinator:** Provides financial assistance, transportation, healthcare referrals. Contact: 626-256-4673, ext. 32273.
- **Clinical Social Workers:** Assist with financial benefit guidance, including state and social security disability, and paid family leave benefits.
- **Sheri & Les Biller Patient and Family Resource Center:** A central hub for support services, offering resources to empower patients throughout their treatment.
- **Cancer Legal Resource Center (CLRC):** Offers education and support on employment, healthcare access, government benefits, medical leave, and estate planning.
**Financial Assistance Application:**
Patients can apply for financial assistance at any stage of their treatment. The application process involves completing a Financial Evaluation Form with the help of Financial Support Services Counselors and submitting necessary documentation. Pre-screening requests can be made by calling (844) 936-4673. Applications can also be initiated via the patient portal.
What insurance does City of Hope Comprehensive Cancer Center accept?
The City of Hope Comprehensive Cancer Center accepts a variety of insurance plans, including PPO, Covered California, HMO, and Medicare. For Covered California, it accepts Blue Shield of California EPO/PPO and OSCAR Health Plan of California EPO at all levels for services at their clinical network locations, though OSCAR Health Plan - City of Hope Medical Center in Duarte is out-of-network. For accurate estimates, contact their financial counselors at (833) 915-4673.
What awards or recognition has City of Hope Comprehensive Cancer Center received?
City of Hope Comprehensive Cancer Center, located in Duarte, California, is a National Cancer Institute-designated comprehensive cancer center, recognized for its excellence in cancer treatment, research, and expertise. It is a founding member of the National Comprehensive Cancer Network, showcasing its leadership in cancer research and treatment advancements. Consistently ranked among the top cancer centers in the United States by U.S. News & World Report, it has secured a position in the top 10 for the past two years.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.